ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,497Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 337

$1.5M Total Retail Price of All Prescriptions

Rank: 6 out of 337

768 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 768 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 768 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 22,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
FUROSEMIDE 1,009 911 1 8
WARFARIN SODIUM 995 922 2 11
TRAZODONE HCL 895 717 3 16
OMEPRAZOLE 845 737 4 4
METOPROLOL TARTRATE 840 746 5 6
LEVOTHYROXINE SODIUM 748 675 6 5
SIMVASTATIN 684 575 7 1
LISINOPRIL 648 572 8 2
HYDROCODONE-ACETAMINOPHEN 537 258 S3 9 13
CITALOPRAM HBR 535 435 10 17
SERTRALINE HCL 531 430 11 18
AMLODIPINE BESYLATE 519 458 12 3
DONEPEZIL HCL 450 420 13 22
TRAMADOL HCL 379 350 14 32
GABAPENTIN 372 293 15 20
HYDROCHLOROTHIAZIDE 352 334 16 9
NAMENDA 350 334 17 35
MIRTAZAPINE 336 288 18 27
ATENOLOL 327 291 19 10
QUETIAPINE FUMARATE 311 273 20 61
PRAVASTATIN SODIUM 306 281 21 14
ATORVASTATIN CALCIUM 304 286 22 7
OXYCODONE HCL 299 109 S2 23 63
TAMSULOSIN HCL 243 228 24 25
CYMBALTA 239 197 25 59
METFORMIN HCL 233 219 26 12
LANTUS 232 202 27 49
POLYETHYLENE GLYCOL 3350 225 162 28 47
VENLAFAXINE HCL ER 224 174 29 86
CLOPIDOGREL 217 173 30 42
RISPERIDONE 216 147 31 72
RANITIDINE HCL 192 156 32 30
SPIRIVA 187 147 33 43
DIOVAN 185 166 34 26
POTASSIUM CHLORIDE 182 166 35 62
GLIPIZIDE 179 160 36 45
DIVALPROEX SODIUM 172 129 37 101
LOSARTAN POTASSIUM 171 165 38 15
METOPROLOL SUCCINATE 170 142 39 21
ESCITALOPRAM OXALATE 164 142 40 66
EXELON 163 163 41 85
ZOLPIDEM TARTRATE 158 119 42 23
ALLOPURINOL 154 152 43 28
RAMIPRIL 153 148 44 80
CIPROFLOXACIN HCL 151 133 45 71
OXYBUTYNIN CHLORIDE ER 145 109 46 124
SULFAMETHOXAZOLE-TRIMETHOPRIM 144 120 47 139
PANTOPRAZOLE SODIUM 140 98 48 36
OXYCODONE-ACETAMINOPHEN 137 62 S2 49 84
CARBIDOPA-LEVODOPA 136 131 50 92
LIDODERM 135 110 51 82
ALENDRONATE SODIUM 128 128 52 19
NOVOLOG 127 114 53 106
LEVETIRACETAM 125 84 54 112
PLAVIX 122 97 55 74
PROAIR HFA 116 76 56 38
ABILIFY 115 77 57 145
PREDNISONE 114 97 58 40
CARVEDILOL 107 95 59 73
LACTULOSE 107 89 59 105
ADVAIR DISKUS 106 73 61 44
ENALAPRIL MALEATE 104 94 62 37
LIPITOR 101 95 63 33
LEVOFLOXACIN 99 84 64 93
ROPINIROLE HCL 96 88 65 141
QUINAPRIL HCL 95 93 66 50
DIGOXIN 94 94 67 58
PAROXETINE HCL 93 87 68 46
IPRATROPIUM-ALBUTEROL 89 84 69 96
CLOZAPINE 87 0 70 94
GLIPIZIDE ER 85 69 71 69
PHENYTOIN SODIUM EXTENDED 83 40 72 150
BACLOFEN 82 15 73 133
DILTIAZEM 24HR CD 82 80 73 104
ISOSORBIDE MONONITRATE ER 79 51 75 70
AZITHROMYCIN 79 67 75 51
FLUOXETINE HCL 78 49 77 57
LAMOTRIGINE 77 35 78 188
SEROQUEL 74 69 79 107
FLUTICASONE PROPIONATE 73 55 80 34
FINASTERIDE 73 73 80 83
VENLAFAXINE HCL 73 73 80 168
GLYBURIDE 70 70 R 83 53
OXYCODONE HCL-ACETAMINOPHEN 69 31 S2 84 152
OLANZAPINE 68 44 85 108
HYDRALAZINE HCL 68 48 85 122
BENZTROPINE MESYLATE 67 48 R 87 172
VERAPAMIL ER 64 64 88 77
NEXIUM 63 63 89 56
BUSPIRONE HCL 63 63 89 129
PROCHLORPERAZINE MALEATE 59 42 91 222
SPIRONOLACTONE 57 44 92 100
VENTOLIN HFA 57 46 92 159
NITROFURANTOIN MONO-MACRO 57 40 92 197
CEPHALEXIN 56 50 95 130
OXYCONTIN 56 27 S2 95 87
FAMOTIDINE 56 33 95 115
KLOR-CON M20 55 38 98 65
LEXAPRO 55 48 98 169
LOSARTAN-HYDROCHLOROTHIAZIDE 54 34 100 60
AMITRIPTYLINE HCL 52 24 R 101 75
FENOFIBRATE 52 52 101 48
TRIAMTERENE-HCTZ 52 52 101 39
AMOX TR-POTASSIUM CLAVULANATE 52 42 101 137
LABETALOL HCL 52 36 101 149
SYMBICORT 51 40 106 151
PATANOL 51 49 106 317
NAPROXEN 51 41 106 98
MELOXICAM 50 39 109 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.